American Heart Association Scientific Sessions

Healio brings you the highlights from the American Heart Association Scientific Sessions. Refer back to this page often for the latest news from AHA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

OSLER-1 trial demonstrates efficacy, safety of evolocumab in hypercholesterolemia

December 17, 2018
CHICAGO – Treatment with evolocumab decreased LDL cholesterol consistently without escalating the rate of adverse events or leading to the…
Meeting News

Liraglutide, semaglutide beneficial in diabetes regardless of baseline BMI, BP

December 14, 2018
CHICAGO — Two post-hoc analyses of data from the LEADER and SUSTAIN 6 trials presented at the American Heart Association Scientific Sessions…
Meeting News

Emphasize patient adherence, dietary patterns in recommending diets for patients with diabetes

December 13, 2018
CHICAGO — While diets that emphasize increasing or decreasing a single nutrient class, such as high-carbohydrate or low-fat diets, are trending…
Meeting News

IABPs fail to reduce mortality in acute MI with cardiogenic shock

December 12, 2018
CHICAGO — Long-term follow-up from the IABP-SHOCK II trial shows that the use of intra-aortic balloon pumps for hemodynamic support had no…
Meeting News

Aggressive intervention improves glycemic control among non-adherent patients with diabetes

December 6, 2018
CHICAGO —Aggressive intervention with insulin in patients with type 2 diabetes who were at risk for being non-adherent resulted in improved…
Meeting News

Direct oral anticoagulant use lower with higher CHA2DS2-VASc score

December 6, 2018
CHICAGO — New data presented at the American Heart Association Scientific Sessions suggest that in a real-world setting, use of direct oral…
Meeting News

Broken heart syndrome complicated by cardiogenic shock tied to unfavorable short-, long-term outcomes

December 6, 2018
CHICAGO — When patients with takotsubo syndrome survive cardiogenic shock, they remain at greater risk for unfavorable outcomes, including risk…
Meeting News

ACCORD: Premixed insulin use, renal events predict CV outcomes in patients with diabetes

December 4, 2018
CHICAGO — A new analysis of data from the ACCORD trial showed that use of premixed insulin and renal microvascular events predicted the…
Meeting News

New-onset AF similar after TAVR, surgical AVR

November 30, 2018
CHICAGO — Patients who underwent transcatheter aortic valve replacement had a comparable incidence of new-onset atrial fibrillation compared…
Meeting News

Dapagliflozin confers more favorable cardiometabolic outcomes vs. vildagliptin

November 29, 2018
CHICAGO — The SGLT2 inhibitor dapagliflozin was more beneficial than the DPP4 inhibitor vildagliptin in reducing BMI and systolic BP and…